Skleritis (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Skleritis" in Serbian language version.

refsWebsite

Global rank Serbian rank

16nih.gov

4^th place

8^th place

16doi.org

2^nd place

4^th place

9archive.org

6^th place

5^th place

1touchophthalmology.com

low place

1webmd.com

1,169^th place

914^th place

1healthline.com

3,733^rd place

783^rd place

1reviewofoptometry.com

low place

1aao.org

low place

5,856^th place

1medscape.com

719^th place

468^th place

aao.org (Global: low place; Serbian: 5,856^th place)

„What Is Scleritis?”. American Academy of Ophthalmology (на језику: енглески). 2020-08-04. Приступљено 2021-02-04.

archive.org (Global: 6^th place; Serbian: 5^th place)

Watson, P. G.; Hayreh, S. S. (1976). „Scleritis and episcleritis”. Br J Ophthalmol. 60 (3): 163—7. PMC 1042706 . PMID 1268179. doi:10.1136/bjo.60.3.163.
Sainz de la Maza, Maite; Molina, Nicolas; Gonzalez-Gonzalez, Luis Alonso; Doctor, Priyanka P.; Tauber, Joseph; Foster, C. Stephen (2012). „Scleritis Therapy”. Ophthalmology. 119 (1): 51—8. PMID 22015381. doi:10.1016/j.ophtha.2011.07.043.
McCluskey PJ, Watson PG, Lightman S, et al., Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients, McCluskey, P. J.; Watson, P. G.; Lightman, S.; Haybittle, J.; Restori, M.; Branley, M. (1999). „Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients”. Ophthalmology. 106 (12): 2380—6. PMID 10599675. doi:10.1016/S0161-6420(99)90543-2. .
McCluskey, P. J.; Watson, P. G.; Lightman, S.; Haybittle, J.; Restori, M.; Branley, M. (1999). „Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients”. Ophthalmology. 106 (12): 2380—6. PMID 10599675. doi:10.1016/S0161-6420(99)90543-2.
Sainz de la Maza M; Molina, N.; Gonzalez-Gonzalez, L. A.; Doctor, P. P.; Tauber, J.; Foster, C. S. (2012). „Clinical characteristics of a large cohort of patients with scleritis and episcleritis”. Ophthalmology. 119 (1): 43—50. PMID 21963265. doi:10.1016/j.ophtha.2011.07.013. .
Jabs, D. A.; Mudun, A.; Dunn, J. P.; Marsh, M. J. (2000). „Episcleritis and scleritis: Clinical features and treatment results”. American Journal of Ophthalmology. 130 (4): 469—76. PMID 11024419. doi:10.1016/S0002-9394(00)00710-8.
Reynolds MG, Alfonso E, Treatment of infectious scleritis and keratoscleritis (1991). „Treatment of infectious scleritis and keratoscleritis”. American Journal of Ophthalmology. 112 (5): 543—7. PMID 1951592. doi:10.1016/s0002-9394(14)76856-4. Непознати параметар |DUPLICATE_date= игнорисан (помоћ).
Stone JH, Merkel PA, Spiera R, Seo P, et al., Rituximab versus cyclophosphamide for ANCA-associated vasculitis (2010). „Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis”. New England Journal of Medicine. 363 (3): 221—232. PMID 20647199. doi:10.1056/NEJMoa0909905. .
Murphy CC, Ayliffe WH, Booth A, et al., Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis (2004). „Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis”. Ophthalmology. 111 (2): 352—356. PMID 15019389. doi:10.1016/S0161-6420(03)00721-8. .

doi.org (Global: 2^nd place; Serbian: 4^th place)

Hodson, Kelly L.; Galor, Anat; Karp, Carol L.; Davis, Janet L.; Albini, Thomas A.; Perez, Victor L.; Miller, Darlene; Forster, Richard K. (2013). „Epidemiology and Visual Outcomes in Patients with Infectious Scleritis”. Cornea. 32 (4): 466—72. PMID 22902495. doi:10.1097/ICO.0b013e318259c952.
Jain, V.; Garg, P.; Sharma, S. (2009). „Microbial scleritis-experience from a developing country”. Eye. 23 (2): 255—61. PMID 18219336. doi:10.1038/sj.eye.6703099.
Watson, P. G.; Hayreh, S. S. (1976). „Scleritis and episcleritis”. Br J Ophthalmol. 60 (3): 163—7. PMC 1042706 . PMID 1268179. doi:10.1136/bjo.60.3.163.
Okhravi N, Odufuwa B, McCluskey P, Lightman S, Scleritis (2005). „Scleritis”. Surv Ophthalmol. 50 (4): 351—63. PMID 15967190. doi:10.1016/j.survophthal.2005.04.001. .
Wakefield, Denis; Di Girolamo, Nick; Thurau, Stephan; Wildner, Gerhild; McCluskey, Peter (2013). „Scleritis: Immunopathogenesis and molecular basis for therapy”. Progress in Retinal and Eye Research. 35: 44—62. PMID 23454614. doi:10.1016/j.preteyeres.2013.02.004.
Cao, J. H.; Oray, M.; Cocho, L.; Foster, C. S. (2016). „Rituximab in the Treatment of Refractory Noninfectious Scleritis”. American Journal of Ophthalmology. 164: 22—8. PMID 26766304. doi:10.1016/j.ajo.2015.12.032.
Sainz de la Maza, Maite; Molina, Nicolas; Gonzalez-Gonzalez, Luis Alonso; Doctor, Priyanka P.; Tauber, Joseph; Foster, C. Stephen (2012). „Scleritis Therapy”. Ophthalmology. 119 (1): 51—8. PMID 22015381. doi:10.1016/j.ophtha.2011.07.043.
McCluskey PJ, Watson PG, Lightman S, et al., Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients, McCluskey, P. J.; Watson, P. G.; Lightman, S.; Haybittle, J.; Restori, M.; Branley, M. (1999). „Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients”. Ophthalmology. 106 (12): 2380—6. PMID 10599675. doi:10.1016/S0161-6420(99)90543-2. .
McCluskey, P. J.; Watson, P. G.; Lightman, S.; Haybittle, J.; Restori, M.; Branley, M. (1999). „Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients”. Ophthalmology. 106 (12): 2380—6. PMID 10599675. doi:10.1016/S0161-6420(99)90543-2.
Sainz de la Maza M; Molina, N.; Gonzalez-Gonzalez, L. A.; Doctor, P. P.; Tauber, J.; Foster, C. S. (2012). „Clinical characteristics of a large cohort of patients with scleritis and episcleritis”. Ophthalmology. 119 (1): 43—50. PMID 21963265. doi:10.1016/j.ophtha.2011.07.013. .
Jabs, D. A.; Mudun, A.; Dunn, J. P.; Marsh, M. J. (2000). „Episcleritis and scleritis: Clinical features and treatment results”. American Journal of Ophthalmology. 130 (4): 469—76. PMID 11024419. doi:10.1016/S0002-9394(00)00710-8.
Reynolds MG, Alfonso E, Treatment of infectious scleritis and keratoscleritis (1991). „Treatment of infectious scleritis and keratoscleritis”. American Journal of Ophthalmology. 112 (5): 543—7. PMID 1951592. doi:10.1016/s0002-9394(14)76856-4. Непознати параметар |DUPLICATE_date= игнорисан (помоћ).
Stone JH, Merkel PA, Spiera R, Seo P, et al., Rituximab versus cyclophosphamide for ANCA-associated vasculitis (2010). „Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis”. New England Journal of Medicine. 363 (3): 221—232. PMID 20647199. doi:10.1056/NEJMoa0909905. .
Bielefeld P, Muselier A, Devilliers H; et al. (2015). „Cotrimoxazole as a treatment for recurrent idiopathic anterior scleritis: A single-center experience in 20 patients”. Ocular Immunology & Inflammation. 23 (2): 184—7. PMID 24432898. doi:10.3109/09273948.2013.874446. .
Doctor P, Sultan A, Syed S, et al., Infliximab for the treatment of refractory scleritis (2010). „Infliximab for the treatment of refractory scleritis”. Br J Ophtahlmol. 94 (5): 579—583. PMC 2976470 . PMID 19955205. doi:10.1136/bjo.2008.150961. .
Murphy CC, Ayliffe WH, Booth A, et al., Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis (2004). „Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis”. Ophthalmology. 111 (2): 352—356. PMID 15019389. doi:10.1016/S0161-6420(03)00721-8. .

healthline.com (Global: 3,733^rd place; Serbian: 783^rd place)

„Scleritis: Risk Factors, Causes, and Symptoms”. Healthline (на језику: енглески). 2016-12-20. Приступљено 2021-02-04.

medscape.com (Global: 719^th place; Serbian: 468^th place)

emedicine.medscape.com

„Scleritis”. WebMD, LLC. Medscape. 15. 11. 2022. Приступљено 13. 11. 2018.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Hodson, Kelly L.; Galor, Anat; Karp, Carol L.; Davis, Janet L.; Albini, Thomas A.; Perez, Victor L.; Miller, Darlene; Forster, Richard K. (2013). „Epidemiology and Visual Outcomes in Patients with Infectious Scleritis”. Cornea. 32 (4): 466—72. PMID 22902495. doi:10.1097/ICO.0b013e318259c952.
Jain, V.; Garg, P.; Sharma, S. (2009). „Microbial scleritis-experience from a developing country”. Eye. 23 (2): 255—61. PMID 18219336. doi:10.1038/sj.eye.6703099.
Watson, P. G.; Hayreh, S. S. (1976). „Scleritis and episcleritis”. Br J Ophthalmol. 60 (3): 163—7. PMC 1042706 . PMID 1268179. doi:10.1136/bjo.60.3.163.
Okhravi N, Odufuwa B, McCluskey P, Lightman S, Scleritis (2005). „Scleritis”. Surv Ophthalmol. 50 (4): 351—63. PMID 15967190. doi:10.1016/j.survophthal.2005.04.001. .
Wakefield, Denis; Di Girolamo, Nick; Thurau, Stephan; Wildner, Gerhild; McCluskey, Peter (2013). „Scleritis: Immunopathogenesis and molecular basis for therapy”. Progress in Retinal and Eye Research. 35: 44—62. PMID 23454614. doi:10.1016/j.preteyeres.2013.02.004.
Cao, J. H.; Oray, M.; Cocho, L.; Foster, C. S. (2016). „Rituximab in the Treatment of Refractory Noninfectious Scleritis”. American Journal of Ophthalmology. 164: 22—8. PMID 26766304. doi:10.1016/j.ajo.2015.12.032.
Sainz de la Maza, Maite; Molina, Nicolas; Gonzalez-Gonzalez, Luis Alonso; Doctor, Priyanka P.; Tauber, Joseph; Foster, C. Stephen (2012). „Scleritis Therapy”. Ophthalmology. 119 (1): 51—8. PMID 22015381. doi:10.1016/j.ophtha.2011.07.043.
McCluskey PJ, Watson PG, Lightman S, et al., Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients, McCluskey, P. J.; Watson, P. G.; Lightman, S.; Haybittle, J.; Restori, M.; Branley, M. (1999). „Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients”. Ophthalmology. 106 (12): 2380—6. PMID 10599675. doi:10.1016/S0161-6420(99)90543-2. .
McCluskey, P. J.; Watson, P. G.; Lightman, S.; Haybittle, J.; Restori, M.; Branley, M. (1999). „Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients”. Ophthalmology. 106 (12): 2380—6. PMID 10599675. doi:10.1016/S0161-6420(99)90543-2.
Sainz de la Maza M; Molina, N.; Gonzalez-Gonzalez, L. A.; Doctor, P. P.; Tauber, J.; Foster, C. S. (2012). „Clinical characteristics of a large cohort of patients with scleritis and episcleritis”. Ophthalmology. 119 (1): 43—50. PMID 21963265. doi:10.1016/j.ophtha.2011.07.013. .
Jabs, D. A.; Mudun, A.; Dunn, J. P.; Marsh, M. J. (2000). „Episcleritis and scleritis: Clinical features and treatment results”. American Journal of Ophthalmology. 130 (4): 469—76. PMID 11024419. doi:10.1016/S0002-9394(00)00710-8.
Reynolds MG, Alfonso E, Treatment of infectious scleritis and keratoscleritis (1991). „Treatment of infectious scleritis and keratoscleritis”. American Journal of Ophthalmology. 112 (5): 543—7. PMID 1951592. doi:10.1016/s0002-9394(14)76856-4. Непознати параметар |DUPLICATE_date= игнорисан (помоћ).
Stone JH, Merkel PA, Spiera R, Seo P, et al., Rituximab versus cyclophosphamide for ANCA-associated vasculitis (2010). „Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis”. New England Journal of Medicine. 363 (3): 221—232. PMID 20647199. doi:10.1056/NEJMoa0909905. .
Bielefeld P, Muselier A, Devilliers H; et al. (2015). „Cotrimoxazole as a treatment for recurrent idiopathic anterior scleritis: A single-center experience in 20 patients”. Ocular Immunology & Inflammation. 23 (2): 184—7. PMID 24432898. doi:10.3109/09273948.2013.874446. .
Doctor P, Sultan A, Syed S, et al., Infliximab for the treatment of refractory scleritis (2010). „Infliximab for the treatment of refractory scleritis”. Br J Ophtahlmol. 94 (5): 579—583. PMC 2976470 . PMID 19955205. doi:10.1136/bjo.2008.150961. .
Murphy CC, Ayliffe WH, Booth A, et al., Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis (2004). „Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis”. Ophthalmology. 111 (2): 352—356. PMID 15019389. doi:10.1016/S0161-6420(03)00721-8. .

reviewofoptometry.com (Global: low place; Serbian: low place)

OD, By Jim Williamson. „A Red Eye: Scleritis or Episcleritis?”. www.reviewofoptometry.com. Приступљено 2021-02-04.

touchophthalmology.com (Global: low place; Serbian: low place)

„Scleritis—Infectious Versus Inflammatory”. US Ophthalmic Review (на језику: енглески). 2016-10-10.

webmd.com (Global: 1,169^th place; Serbian: 914^th place)

„What Is Scleritis?”. WebMD (на језику: енглески). Приступљено 2021-02-04.

Skleritis (Serbian Wikipedia)

aao.org (Global: low place; Serbian: 5,856th place)

archive.org (Global: 6th place; Serbian: 5th place)

doi.org (Global: 2nd place; Serbian: 4th place)

healthline.com (Global: 3,733rd place; Serbian: 783rd place)

medscape.com (Global: 719th place; Serbian: 468th place)

emedicine.medscape.com

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

reviewofoptometry.com (Global: low place; Serbian: low place)

touchophthalmology.com (Global: low place; Serbian: low place)

webmd.com (Global: 1,169th place; Serbian: 914th place)

aao.org (Global: low place; Serbian: 5,856^th place)

archive.org (Global: 6^th place; Serbian: 5^th place)

doi.org (Global: 2^nd place; Serbian: 4^th place)

healthline.com (Global: 3,733^rd place; Serbian: 783^rd place)

medscape.com (Global: 719^th place; Serbian: 468^th place)

nih.gov (Global: 4^th place; Serbian: 8^th place)

webmd.com (Global: 1,169^th place; Serbian: 914^th place)